Identifying biomarkers for different types of lower urinary tract symptoms and their treatment responses
Official title: Identification of biomarker signatures of subtypes of LUTS and their response to treatments using samples from LURN study
Funded at Arbor Research Collaborative for Health · NIH-10413153 · Data updated 2026-11-12
This study is looking at how certain markers in your blood can help doctors better understand and treat different types of lower urinary tract symptoms (LUTS), using samples from a large group of people to find out what works best for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arbor Research Collaborative for Health NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 1, 2020 |
| Project end | June 30, 2025 |
| Funding year | 2022 |
| Award (this year) | $213,678 |
| NIH project number | 5R01DK125251-03 |
| Project ID | NIH-10413153 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include men and women experiencing lower urinary tract symptoms, particularly those who have undergone treatment.
✕Less likely to help
Patients with LUTS who are not seeking treatment or those with unrelated urinary conditions may not benefit from this research.
What this research studies
This research investigates lower urinary tract symptoms (LUTS) by analyzing blood samples to identify specific biomarkers that can differentiate between various subtypes of LUTS. By utilizing over 75,000 biosamples collected from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN), the study aims to uncover how these biomarkers relate to treatment responses. The goal is to improve the understanding of LUTS and enhance clinical management by providing tools that can accurately classify and predict patient outcomes based on their biomarker profiles.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for patients suffering from LUTS.
How similar studies have gone: Previous research has shown promise in identifying biomarkers for LUTS, but this study aims to address existing gaps and improve upon those findings.
Where this research is happening
-
Arbor Research Collaborative for Health
Ann Arbor, United States Active
Researchers
- Principal investigator: Andreev, Victor P. — Arbor Research Collaborative for Health
- Study coordinator: Andreev, Victor P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.